Author: Bill Snyder
Oct. 3, 2011—Researchers at Vanderbilt University Medical Center have made substantial progress in developing potential new treatments for Parkinson’s disease, schizophrenia and fragile X syndrome, the most common genetic form of autism.
Sep. 30, 2011—Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.
Sep. 27, 2011—A state-of-the-art interactive exhibit on the brain and brain research has opened at Vanderbilt Health One Hundred Oaks.
Sep. 22, 2011—The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia.
Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.
Aug. 31, 2011—Art and science are not mutually exclusive. On the contrary, these two important fields of human endeavor often draw from and inspire each other. Think Leonardo da Vinci and Benjamin Franklin. A 21st century version of this cross-fertilization currently is on display at Nashville’s gallery F. @ Scarritt Bennett, 1000 19th Ave. S. (corner of...
Aug. 30, 2011—In addition to her high school diploma, Aziza Hart earned an unusual honor this spring – her first scientific paper was published in a new Vanderbilt University journal, Young Scientist. Hart, who graduated from Nashville’s Glencliff High School, spent part of her senior year in a Vanderbilt laboratory, studying a brain abnormality that could lead...
Aug. 18, 2011—Researchers have discovered how key proteins are “turned on” and transmit signals inside the cell. The discovery could lead to new, more effective drugs.
Aug. 10, 2011—Vanderbilt researchers have identified small molecules that can restore normal protein expression in human colorectal carcinoma cells and prevent invasive cancer growth.
Jul. 18, 2011—Vanderbilt University Medical Center has been awarded a five-year $20 million federal grant to coordinate a national consortium that aims to advance biomedical research nationwide.